See All Slides - tctmd.com

Slides

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Presenter: Juan F. Granada, Michael Joner

October 11, 2015

Presentation TCT 2015

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? The Mechanism and Data Support Cangrelor!

Presenter: C. Michael Gibson, Marco Valgimigli, Harvey D. White

October 11, 2015

Presentation TCT 2015

Everolimus-Eluting Bioabsorbable-Polymer DES Outcomes: SYNERGY Update

Presenter: Stephen G. Ellis, John A. Ormiston, Dean J. Kereiakes

October 11, 2015

Presentation TCT 2015

The Retrograde Approach: J-CTO Registry Insights

Presenter: J. Aaron Grantham, Masahiko Ochiai, Etsuo Tsuchikane

October 11, 2015

Presentation TCT 2015

The New MVARC Consensus Documents: Take-home Messages

Presenter: Patrick T. O'Gara, Allan Schwartz, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

Review and Perspectives of the Global Registry Data for Antiproliferative Therapies

Presenter: Gary M. Ansel, Michael R. Jaff, John R. Laird Jr

October 11, 2015

Presentation TCT 2015

STEMI: Treatment Strategies, Drugs, and Devices

Presenter: Tayo A. Addo, Dharam J. Kumbhani

October 11, 2015

Presentation TCT 2015

USA Presents: Scaffold-Vessel Interactions: What the Interventionalist Should Know

Presenter: George D. Dangas, Eric Van Belle, Richard J. Rapoza

October 11, 2015

Presentation TCT 2015

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Piera Capranzano

October 11, 2015

Advertisement

Slides

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? The Mechanism and Data Support Cangrelor!

Everolimus-Eluting Bioabsorbable-Polymer DES Outcomes: SYNERGY Update

The Retrograde Approach: J-CTO Registry Insights

The New MVARC Consensus Documents: Take-home Messages

Review and Perspectives of the Global Registry Data for Antiproliferative Therapies

STEMI: Treatment Strategies, Drugs, and Devices

USA Presents: Scaffold-Vessel Interactions: What the Interventionalist Should Know

Shades of Gray? Defining the Range of Patients Contraindicated for Anticoagulation

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content